Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of BF-Metoprolol vs Betaloc in Healthy Volunteers
NCT03082352Phase 1Unknown
- Sponsor
- Bright Future Pharmaceutical Laboratories Limited
- Start
- Aug 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of metoprolol in hypertension (HTN) (2 arms), sponsored by Bright Future Pharmaceutical Laboratories Limited. Primary endpoints: Peak Plasma Concentration at 24 hours and Area Under the Plasma Concentration-Time Curve at 24 hours. Status: unknown.
02
Drugs
metoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03082352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082352.